Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
Authors:
El-Khoueiry A, Saavedra O, Thomas J, [...]one or more additional authors omittedBerrien-Elliott MM, [...]one or more additional authors omitted Lopez J
